Site Search

... H.R. 1826, the Prostate-Specific Antigen Screening for High-risk Insured Men (PSA Screening for HIM) Act was introduced in the U.S. House of Representatives by Representatives Larry Buschon for support and Yvette Clarke (D-NY) with Representatives Neal Dunn, M.D. (R-FL) and Troy Carter (D-LA) as original cosponsors. This bipartisan legislative proposal would waive cost-sharing requirements for men with the highest risk of prostate cancer, focusing on Black men and those with a family history of the disease. ... 31%. ZERO - The End of Prostate Cancer , the American Urological Association (AUA), and the American Cancer Society Cancer Action Network (ACS CAN) are ongoing supporters of the bill and are working to pass legislation at both the state and national levels to eliminate out-of-pocket costs ...

MONTGOMERY, Ala. – Patient advocacy groups including the American Cancer Society Cancer Action Network (ACS CAN) and ZERO Prostate Cancer applaud Alabama State Sen. Steve Livingston for pre-filing Senate Bill 19 , which eliminates cost sharing for lifesaving prostate cancer screenings for those covered by state-regulated insurance. The bill, which was pre-filed this month in honor of Prostate Cancer Awareness Month, would reduce barriers for men over 40 at high risk of developing prostate cancer. If passed, Alabama would ...

... New federal legislation that would make it easier for all cancer patients to participate in clinical trials was introduced today in the House of Representatives. Sponsored by U.S. Reps. Raul Ruiz (D-Calif.) and August Pfluger (R-Texas), the Clinical Trial Modernization Act would help remove cost and geographic hurdles that prevent patients from participating in clinical trials. The legislation would enable clinical trial sponsors to ... incomes, people who live in rural areas and certain racial and ethnic groups. According to an American Cancer Society Cancer Action Network (ACS CAN) survey, 79% of cancer patients and survivors indicated they would be more likely to enroll in a clinical trial if sponsors supported them ...

... Senate Bill 912 will enable more Californians to benefit from biomarker testing, a critical step in accessing precision medicine treatments that can lead to fewer side effects, improved survival, better quality of life and potentially lower costs for some cancer patients. But to determine if a patient will benefit from certain targeted therapies, doctors ... Ogden-Smith, California Legislative Director for the American Cancer Society Cancer Action Network (ACS CAN). “It’s imperative we dismantle cost barriers in order to address and help reduce health disparities.” Communities that have been under-resourced, including communities of ...